心脏胆碱能活性的首次人体[18F]FEOBV PET显像与动力学分析
本研究在4名健康受试者中注射230±50 MBq的[18F]FEOBV后进行40分钟动态心脏PET采集,采用Logan图形分析、一室和二室模型拟合左心室时间-活度曲线,各模型得到的分布容积估计相似。初步数据显示[18F]FEOBV PET具有适合定量心脏胆碱能活性的示踪动力学特性,是评估心脏副交感功能的有前景的新方法。
要点
- [18F]FEOBV PET在健康人心脏中展现出适合定量胆碱能活性的示踪动力学。
- Logan图形分析、一室及二室模型给出的分布容积估计在各受试者中相似。
- 该方法有望填补心脏副交感(胆碱能)活性在体定量评估的工具空白。
核心结论
- [18F]FEOBV PET具有适合定量心脏胆碱能活性的良好示踪动力学,是评估心脏副交感功能的有前景的新方法。
研究设计与样本
- 首次人体研究,纳入4名健康受试者(1名女性;年龄37±10岁;BMI 25±2),注射230±50 MBq [18F]FEOBV后采集40分钟动态心脏PET数据。
- 采用Logan图形分析、一室模型和二室模型拟合左心室时间-活度曲线,比较各模型得到的分布容积估计。
主要发现
- 四个健康受试者中,Logan图形分析、一室模型和二室模型给出的分布容积估计相似。
- [18F]FEOBV PET在心脏中表现出适合定量胆碱能活性的示踪动力学特性。
临床怎么用
- 目前尚处首次人体研究阶段,[18F]FEOBV PET可作为研究工具用于心脏胆碱能活性映射,暂不宜直接用于临床常规。
局限性
- 样本量仅4名健康受试者,未在患者群体中验证。
- 研究仅评估示踪动力学特性,未与金标准或其他副交感功能指标进行对比验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
In contrast to cardiac sympathetic activity which can be assessed with established PET tracers, there are currently no suitable radioligands to measure cardiac parasympathetic (cholinergic) activity. A radioligand able to measure cardiac cholinergic activity would be an invaluable clinical and research tool since cholinergic dysfunction has been associated with a wide array of pathologies (e.g., chronic heart failure, myocardial infarction, arrythmias). [18F]Fluoroethoxybenzovesamicol (FEOBV) is a cholinergic radiotracer that has been extensively validated in the brain. Whether FEOBV PET can be used to assess cholinergic activity in the heart is not known. Hence, this study aimed to evaluate the properties of FEOBV for cardiac PET imaging and cholinergic activity mapping. PET data were collected for 40 minutes after injection of 230 ± 50 MBq of FEOBV in four healthy participants (1 female; Age: 37 ± 10; BMI: 25 ± 2). Dynamic LV time activity curves were fitted with Logan graphical, 1-tissue compartment, and 2-tissue compartment models, yielding similar distribution volume estimates for each participant. Our initial data show that FEOBV PET has favorable tracer kinetics for quantification of cholinergic activity and is a promising new method for assessing parasympathetic function in the heart.
引用
- Saint-Georges Z, Zayed VK, Dinelle K, et al. First-in-human imaging and kinetic analysis of vesicular acetylcholine transporter density in the heart using [18F]FEOBV PET. J Nucl Cardiol. 2020. PMID: 32909238. doi:10.1007/s12350-020-02323-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。